Conference Description

This course is filled and registration is closed!

September 27, 2008
Doubletree Hotel Chicago - Arlington Heights
75 Algonquin Road
Arlington Heights, IL

Tell a friend about this conference

Release Date: September 27, 2008

Expiration Date: September 27, 2008

CME Credits: 4.0*

Estimated Time To Complete CME Activity: 4.0 Hours

Medium/Method: Live Conference

Hardware/Software Requirements: None

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants treating patients with bone dieases

Program Summary:
The purpose of this course is to provide health care professionals with an authoritative review and update on the management of common bone diseases including post menopausal osteoporosis and osteoporosis in men, Paget’s disease and skeletal malignancies. An expert faculty will address state of the art approaches to prevention, diagnosis and treatment of bone disease, including a brief consideration of new drugs in development.

In planning this CME activity the National Association for Continuing Education (NACE) performed a needs assessment. A literature search was conducted, national guidelines were reviewed, survey data was analyzed, and experts in each therapeutic area were consulted to determine gaps in practitioner knowledge, competence or performance. Learning objectives (see below), linked to identified gaps, were developed and will be addressed by each presenter. Each participant will be provided with a syllabus containing presentations, clinical tools, and practical guidelines at the start of the program to be used for future reference.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. describe the epidemiology and pathogenesis of common bone diseases: Osteoporosis, Bone Cancer, Paget’s Disease
2. understand and implement current guidelines for the assessment, diagnosis and treatment of bone diseases
3. be familiar with successful measures to prevent disorders of bone and mineral metabolism
4. participate in discussion of current controversies in the management of bone diseases
5. be aware of the gap between knowledge and practice in the management of bone diseases and strategies for rectifying this
6. recognize and avoid pitfalls in the use of bone densitometry
7. understand the mechanism of action of current approved therapies, as well as those in development
8. recognize the skeletal complications related to bone metastases and cancer therapy
9. identify unmet needs in the management of bone diseases and ongoing research initiatives

Agenda:

7:15-7:45 am		Registration and Continental Breakfast
7:45-8:00		Welcome Remarks David Dempster, PhD
8:00-9:00		Pathophysiology and Treatment of Postmenopausal Osteoporosis and Osteoporosis in Men David Dempster, PhD
9:00-10:00		Cancer and Bone: Pathogenesis and Treatment Kenneth W. Lyles, MD
10:00-10:15		Break
10:15-11:15		Pathophysiology and Treatment of Paget’s Disease G. David Roodman, MD, PhD
11:15-12:00		Interactive Panel and Case Discussion

Faculty:
David W. Dempster, PhD
Professor of Clinical Pathology
Columbia University, New York
Director, Regional Bone Center
Helen Hayes Hospital
West Haverstraw, New York

Kenneth W. Lyles, MD
Professor of Medicine
Duke University Medical Center
Durham, NC

G. David Roodman, MD, PhD
Professor of Medicine Vice Chair for
Research School of Medicine,
University of Pittsburgh
Director, Center for Bone Biology
UPMC Health System
Director, Myeloma Program
at UPCI Pittsburgh, PA

Course Directors: David W. Dempster, PhD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 4 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 4.8 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are disclosed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amgen, Lilly, Novartis, Roche, sanofi-aventis.